Table 1.
Demographics and comorbidities of study participantsa
| Demographics and comorbidities | Intervention group (n=26) | Control group (n=40) | p-value |
|---|---|---|---|
| Female sex | 81% | 75% | 0.77 |
| Age | 75 (72–77) | 81 (77–87) | <0.001 |
| Multiple comorbidities | 69% | 73% | 0.79 |
| Clinical frailty scale | 3 (2–4) | 4 (3–4) | 0.10 |
| Nottingham Hip Fracture Score | 4 (3–5) | 5 (4–5) | 0.03 |
| Hypertension | 35% | 48% | 0.32 |
| Chronic kidney diseaseb | 12% | 10% | 1.0 |
| Chronic respiratory disease | 4% | 15% | 0.23 |
| Vascular | 4% | 0 | – |
| Cerebrovascular disease | 4% | 13% | 0.39 |
| Atrial fibrillation | 13% | 5% | 0.38 |
| Diabetes | 8% | 15% | 0.46 |
aData are percentages or median (interquartile range).
bEstimated glomerular filtration rate <60 mL).